Global Medical Institutes, LLC;Princeton Medical Institute

Princeton, New Jersey 08540

1 studies enrolling now · 9 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Depressive Disorder, Major, Mild Cognitive Impairment, Post Traumatic Stress Disorder, Prodromal Alzheimer's Disease, Smoking Cessation, Vaping Cessation

Studies at this site

• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) — Recruiting now
• Psilocybin for Major Depressive Disorder (MDD) — Running, not enrolling
• A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers — Completed
• Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers — Completed
• A Study of JZP150 in Adults With Posttraumatic Stress Disorder — Completed
• Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease — Completed
• Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder — Completed
• Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202) — Completed
• The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD — Stopped early